More than 800 people will be employed at the plant, which will make more Libre sensors than any of the company’s other facilities.
The Kilkenny, Ireland facility will focus on the global manufacturing of sensors for Abbott’s CGM diabetes devices.
CGMs are prescribed to diabetics to monitor their blood sugar. They're now available and becoming wildly popular for over-the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback